151 related articles for article (PubMed ID: 1137503)
41. Viral persistence in congenital rubella.
Rawls WE
Prog Med Virol; 1974; 18(0):273-88. PubMed ID: 4608455
[No Abstract] [Full Text] [Related]
42. Cross-serological testing of rubella-virus strains.
Banatvala JE; Best JM
Lancet; 1969 Apr; 1(7597):695-7. PubMed ID: 4182653
[No Abstract] [Full Text] [Related]
43. [Lymphocyte transformation test using rubella virus antigen].
Sandow D; Arnold U
Z Gesamte Hyg; 1974 Sep; 20(9):611-3. PubMed ID: 4462335
[No Abstract] [Full Text] [Related]
44. Studies on live rubella vaccine. 3. Field trials with vaccines attenuated by serial passages in primary pig kidney cells.
Suzuki M; Minekawa Y; Osame J; Ueda S; Ogino T
Biken J; 1973 Dec; 16(4):149-54. PubMed ID: 4799206
[No Abstract] [Full Text] [Related]
45. Effect of rubella vaccine on transplacental rubella virus infection in rabbits.
Cohen SM; Deibel R; Collins DN; Schryver GD; Ducharme CP
J Lab Clin Med; 1972 Aug; 80(2):179-89. PubMed ID: 4558011
[No Abstract] [Full Text] [Related]
46. Low level rubella immunity detected by ELISA and specific lymphocyte transformation.
Buimovici-Klein E; O'Beirne AJ; Millian SJ; Cooper LZ
Arch Virol; 1980; 66(4):321-7. PubMed ID: 7447708
[TBL] [Abstract][Full Text] [Related]
47. Cell-mediated immune response in rubella infections.
Buimovici-Klein E; Cooper LZ
Rev Infect Dis; 1985; 7 Suppl 1():S123-8. PubMed ID: 2408312
[TBL] [Abstract][Full Text] [Related]
48. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
Just M; Just V; Berger R; Burkhardt F; Schilt U
Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
[TBL] [Abstract][Full Text] [Related]
49. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
Grillner L
J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
[TBL] [Abstract][Full Text] [Related]
50. The development of an M antibody capture ELISA for rubella IgM.
Bellamy K; Rousseau SA; Gardner PS
J Virol Methods; 1986 Nov; 14(3-4):243-51. PubMed ID: 3539958
[TBL] [Abstract][Full Text] [Related]
51. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
Wilkins J
Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
[TBL] [Abstract][Full Text] [Related]
52. Controlling rubella: problems and perspectives.
Horstmann DM
Ann Intern Med; 1975 Sep; 83(3):412-7. PubMed ID: 1180441
[TBL] [Abstract][Full Text] [Related]
53. Clinical evaluation of a rubella passive hemagglutination test system.
Kilgore JM
J Med Virol; 1979; 3(3):231-6. PubMed ID: 479859
[TBL] [Abstract][Full Text] [Related]
54. [Molecular and biologic characteristics of attenuated rubella viruses].
Lavrent'eva IN
Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):55-9. PubMed ID: 18819408
[TBL] [Abstract][Full Text] [Related]
55. A differential effect of IgM and IgG antibodies on the blastogenic response of lymphocytes to rubella virus.
Lee JC; Sigel MM
Cell Immunol; 1974 Jul; 13(1):22-31. PubMed ID: 4217654
[No Abstract] [Full Text] [Related]
56. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
Hillary IB; Freestone DS
J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
[TBL] [Abstract][Full Text] [Related]
57. A comparative field evaluation of three live, attenuated rubella virus vaccines.
Kehrer AF; Isacson P
Am J Public Health; 1971 Jan; 61(1):152-6. PubMed ID: 5539842
[No Abstract] [Full Text] [Related]
58. Transmission of attenuated rubella vaccines to the human fetus. A preliminary report.
Vaheri A; Vesikari T; Oker-Blom N; Seppala M; Veronelli J; Robbins FC; Parkman PD
Am J Dis Child; 1969 Aug; 118(2):243-6. PubMed ID: 4893825
[No Abstract] [Full Text] [Related]
59. In vitro effects of Rubella virus, strain RA 27/3, on human lymphocytes. II. Specific antigen stimulation in relation to Rubella haemagglutination inhibition antibodies.
Maller R; Sörén L
Acta Pathol Microbiol Scand C; 1977 Aug; 85C(4):307-13. PubMed ID: 899801
[TBL] [Abstract][Full Text] [Related]
60. Intrauterine rubella infection following immunization with rubella vaccine.
Phillips CA; Maeck JV; Rogers WA; Savel H
JAMA; 1970 Jul; 213(4):624-5. PubMed ID: 4988108
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
